Aigen Investment Management, LP Collegium Pharmaceutical, Inc Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$21.16 - $30.8 $232,633 - $338,615
10,994 New
10,994 $338,000
Q2 2020

Aug 10, 2020
SELL
$15.49 - $23.51 $10,176 - $15,446
-657 Closed
0 $0
Q1 2020

May 08, 2020
SELL
$13.89 - $25.45 $226,004 - $414,096
-16,271 Reduced 96.12%
657 $11,000
Q4 2019

Feb 04, 2020
BUY
$10.7 - $22.24 $181,129 - $376,478
16,928 New
16,928 $348,000

Others Institutions Holding COLL

# of Institutions
254
Shares Held
36.9M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email